Lymphocytic airway infiltration as a precursor to fibrous obliteration in a rat model of bronchiolitis obliterans

Transplantation

Volumn 64, Issue 2, 1997, Pages 311-317

  Boehler, Annette ^a   Chamberlain, Dean ^a   Kesten, Steven ^a   Slutsky, Arthur S ^a   Liu, Mingyao ^a   Keshavjee, Shaf ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; CONTROLLED STUDY; GRAFT SURVIVAL; IMMUNE MEDIATED INJURY; ISCHEMIA; LUNG TRANSPLANTATION; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRACHEA;

ANIMALS; BRONCHIOLITIS OBLITERANS; DISEASE MODELS, ANIMAL; LYMPHOCYTES; MALE; RATS; RATS, INBRED BN; RATS, INBRED LEW; REPERFUSION INJURY; TIME FACTORS; TRACHEA; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC;

EID: 0030816193     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707270-00023     Document Type: Article

References (30)

1. Hosenpud JD, Novick RJ, Bennett LE, Keck BM, Fiol B, Daily OP. The registry of the International Society for Heart and Lung Transplantation: thirteenth official report-1996. J Heart Lung Transplant 1996; 15: 655.
2. Sundaresan S, Trulock EP, Mohanakumar T, Cooper JD, Patterson GA. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Ann Thorac Surg 1995; 60: 1341.
3. Paradis I, Yousem S, Griffith B. Airway obstruction and bronchiolitis obliterans after lung transplantation. Clin Chest Med 1993; 14: 751.
4. Stewart S. Lung transplant pathology. In: Hammond EH, ed. Solid organ transplantation pathology, Vol. 30. Philadelphia: W.B. Saunders, 1994: 133.
5. Chamberlain DW. Lung transplantation pathology: allograft evaluation. In: Patterson GA, Couraud L, eds. Current topics in general thoracic surgery: an international series. Lung transplantation, Vol. 3. New York: Elsevier Science B.V., 1995: 307.
6. Scott JP, Higenbottam TW, Clelland CA, et al. Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant 1990; 9(5): 510.
7. Yousem SA, Dauber JA, Keenan R, Paradis IL, Zeevi A, Griffith BP Does histologic acute rejection in lung allografts predict the development of bronchiolitis obliterans? Transplantation 1991; 52(2): 306.
8. Abernathy EC, Hruban RH, Baumgartner WA, Reitz BA, Hutchins GM. The two forms of bronchiolitis obliterans in heart-lung transplant recipients. Hum Pathol 1991; 22: 1102.
9. Chamberlain D, Maurer J, Chaparro C, Idolor I. Evaluation of transbronchial lung biopsy in the diagnosis of bronchiolitis obliterans following lung transplantation. J Heart Lung Transplant 1994; 13: 963.
10. Prop J, Merck KW. Lung transplantation in the rat. In: Olszewski WL, ed. CRC handbook of microsurgery, Vol. 2. Boca Raton, FL: CRC Press, 1983: 493.
11. Al-Dossari GA, Kshettry VR, Jessurun J, Bolman RM III. Experimental large-animal model of obliterative bronchiolitis after lung transplantation. Ann Thorac Surg 1994; 58: 34.
12. Hertz MI, Jessurun J, King MB, Savik SK, Murray JJ. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am J Pathol 1993; 142(6): 1945
13. Olech VM, Keshavjee SH, Chamberlain DW, Slutsky AS, Patterson GA. Role of basic fibroblast growth factor in revascularization of rabbit tracheal autografts. Ann Thorac Surg 1991; 52(2): 258.
14. Mayer E, Cardoso PF, Puskas JD, et al. The effect of basic fibroblast growth factor and omentopexy on revascularization and epithelial regeneration of heterotopic rat tracheal isografts. J Thorac Cardiovasc Surg 1992; 104(1): 180.
15. Huang XH, Reichenspurner H, Shorthouse R, Cao W, Berry U, Morris R. Heterotopic tracheal allograft transplantation: a new model to study the molecular events causing obliterative airway disease in rats. J Heart Lung Transplant 1995; 14: S49.
16. Morris RE, Huang X, Gregory CR, et al. Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis. Transplant Proc 1995; 27: 2068.
17. Al-Dossari GA, Jessurun J, Boman RM III, et al. Pathogenesis of obliterative bronchiolitis: possible roles of platelet-derived growth factor and basic fibroblast growth factor. Transplantation 1995; 59: 143.
18. Stolte N, Fehrenbach H, Ochs M, et al. Effects of ischemia and preservation on the ultrastructure of the bronchiolar epithelium: a quantitative electron-microscopic study of human and canine lungs. Virchows Arch A Pathol Anat Histopathol 1996, 429(2-3): 109.
19. Yousem SA, Berry GJ, Brunt EM, et al. A working formulation for the standardization of nomenclature in the diagnose of heart and lung rejection: lung rejection study group. J Heart Lung Transplant 1996; 15: 1.
20. Yousem SA, Berry GJ, Cagle PT, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: lung rejection study group. J Heart Lung Transplant
21. Hruban RH, Beschorner WE, Baumgartner WA, et al. Diagnosis of lung allograft rejection by bronchial intraepithelial Leu-7 positive T lymphocytes. J Thorac Cardiovasc Surg 1988 96: 939.
22. Yousem SA. Lymphocytic bronchitis/bronchiolitis in lung allograft recipients. Am J Surg Pathol 1993; 17(5): 491
23. Penn CC, Liu C. Bronchiolitis following infection in adults and children. In: King TE Jr, ed. Bronchiolitis, Vol. 14(4). Philadelphia: W.B. Saunders, 1993: 645.
24. Wright JL. Inhalational lung injury causing bronchiolitis. In: King TE Jr, ed. Bronchiolitis, Vol. 14(4): Philadelphia: W.B. Saunders, 1993: 635.
25. Shennib H, Serrick C, Corns P, Giaid A. Development of a non-allogeneic animal model of obliterative bronchiolitis [Abstract]. J Heart Lung Transplant 1995; 14(1): S44.
26. Tazelaar HD, Prop J, Nieuwenhuis P, Billingham ME, Wildevuur CRH. Airway pathology in the transplanted rat lung. Transplantation 1988; 45(5): 864.
27. Romaniuk A, Prop J, Peterson AH, Wildevuur CR, Nieuwenhuis P. Expression of class II major histocompatibility complex antigens by bronchial epithelium in rat lung allografts. Transplantion 1987; 44(2): 209.
28. Uyama T, Winter JB, Groen G, Wildevuur CRH, Monden Y, Prop J. Late airway changes caused by chronic rejection in rat lung allografts. Transplantation 1992; 54(5): 809.
29. Yousem SA, Paradis IL, Dauber JA, et al. Large airway inflammation in heart-lung transplant recipients: its significance and prognostic implications. Transplantation 1990; 49(3): 654.
30. Nakanishi R, Yasumoto K. Minimal dose of cyclosporin A for tracheal allografts. Ann Thorac Surg 1995; 60: 635.